|
|
Volumn 6, Issue 6, 2010, Pages 508-512
|
|
Clinical translation of stem cell therapies: A bridgeable gap
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BIOLOGICAL ACTIVITY;
CELL;
CLINICAL PRACTICE;
CLINICAL RESEARCH;
DRUG INDUSTRY;
DRUG SURVEILLANCE PROGRAM;
EUROPE;
GENE THERAPY;
GOOD MANUFACTURING PRACTICE;
GOVERNMENT;
HEALTH CARE ORGANIZATION;
HUMAN;
LAW;
LAW ENFORCEMENT;
MARKETING;
NONHUMAN;
PATIENT SAFETY;
PRIORITY JOURNAL;
PRODUCT DEVELOPMENT;
PURIFICATION;
SAFETY;
SCIENTIST;
SHORT SURVEY;
SOMATIC CELL THERAPY;
SPAIN;
STEM CELL TRANSPLANTATION;
TISSUE ENGINEERING;
|
|
EID: 77956636409
PISSN: 19345909
EISSN: None
Source Type: Journal
DOI: 10.1016/j.stem.2010.05.005 Document Type: Note |
|
Times cited : (50)
|
|
References (11)
|
